More than 60,000 biospecimens from the cohorts are prepared and distributed annually to collaborating laboratories for analyses evaluating the relationship between biomarkers and chronic disease risk.
Biospecimens are available to investigators for approved scientific research projects. Each of the cohort studies has a proud history of successful collaborations with investigators outside the Channing Division of Network Medicine. Because of the highly specific and technical nature of the specimens and their associated data, specimen access is granted through collaborative agreements.
Investigators interested in collaborations are invited to fill out a simple form that asks about the details of the collaboration. Every two weeks, new collaboration requests are reviewed based on feasibility; the vast majority of requests are approved.